NCT06722534View on ClinicalTrials.gov

Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

January 1, 2029

Conditions
Peutz-Jeghers SyndromeCelecoxibSmall Bowel Polyp
Interventions
DRUG

Celecoxib 400mg

Participants in the interventional group receive 200 mg celecoxib twice daily for 6 months

DRUG

Placebo

Participants in the control group receive identically appearing placebo twice daily for 6 months

Trial Locations (1)

710032

RECRUITING

Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an

All Listed Sponsors
lead

Air Force Military Medical University, China

OTHER